Airmid Inc.
Industry
- Pharmaceuticals
- Biotechnology
See more in Biomedtracker
Latest on Airmid Inc.
Scrip
• By Ian Haydock
Merck Serono and the Australian firm Bionomics have decided to end a collaborative discovery research programme focusing on novel oral small molecule inhibitors of the Kv1.3 ion channel for multiple s
Scrip
• By Pial Ganguli
Specialty UK biotech company Circassia plans to progress its ToleroMune cat allergy vaccine into Phase III in the first half 2012 after the follow-up data from its fourth Phase II trial of the product
Scrip
• By Peter Mansell
Circassia, a speciality biopharmaceutical company developing a new class of T-cell vaccines to treat allergies and combat organ transplant rejection, has acquired worldwide development and commerciali